The cost of treatment is stressful, but you may have more options than you think. These advocacy groups offer solutions to help reduce the burden.
Trying to conceive is emotionally taxing enough without adding in the stress of treatment cost. That’s why, in addition to offering medication savings programs, we partner with nonprofit advocacy groups to provide alternative savings options. The following organizations provide loans, grants, or scholarships that can help you manage the cost of treatment when growing your family—or provide support in other areas.*
LIVESTRONG helps men and women diagnosed during their reproductive years understand cancer-related risks to fertility. They also provide access to discounted fertility preservation services and free EMD Serono medication.
To empower Black women to take charge of their fertility and reproductive health, Fertility for Colored Girls offers education, awareness, support, and encouragement to Black women, Black couples, and other women of color who are experiencing infertility and seeking to build a family.
The organization also provides grants through yearly fundraisers to support patients going through IVF treatment.
RESOLVE promotes reproductive health and equal access to all family-building options for men and women experiencing infertility or other reproductive disorders. They also provide financial guidance for treatment.
The Cade Foundation provides educational programs on pathways to parenthood, as well as grants to help families with the cost of adoption and fertility treatment.
INCIID (pronounced “inside”) helps individuals and couples explore their family-building options. They also provide grants for IVF treatment through a series of yearly fundraising events.
This leader in education and financial assistance helps men start families through gestational surrogacy.
With a focus on creating awareness through support in the fertility community, Baby Quest provides financial assistance through fertility grants to those who cannot afford the high cost of advanced procedures such as IVF, gestational surrogacy, egg and sperm donation, egg freezing, artificial insemination, and embryo donation.
The Bundle of Joy Fund advocates for infertility education and awareness, and offers financial assistance for IVF treatment to those struggling to conceive a child through the REACH Clinic of Charlotte.
HelpCureHD is on a mission to prevent the gene that causes Huntington’s Disease, a hereditary brain disorder, from being passed on to future generations. They provide monetary assistance to close the financial gap that stands between some couples and PGT-M IVF, the only option available that guarantees a biological child is HD-free.
Support doesn’t always have to be financial. We also collaborate with organizations that assist fertility and family-building through other efforts.
An advocate for LGBTQ families and those who wish to form them, Family Equality Council focuses on advancing legal and lived equality by building community, changing hearts and minds, and driving policy change.
Comprised of leading experts in the field, The Alliance is on a mission to increase information, resources, and access to fertility preservation for cancer patients and the healthcare professionals who treat them.
Pregnantish helps people with infertility navigate the emotional, personal, and practical realities of an often-overwhelming process. Their mission is to inspire, educate, and connect the millions of women and men who are starting their families.
Call 1-866-LETS-TRY to talk to a Fertility LifeLines® representative today.
Summary of Contraindications Gonal-f® RFF* Redi-ject®, Gonal-f® Multi-Dose and Gonal-f® RFF* 75 IU are contraindicated in patients with prior hypersensitivity to rhFSH or excipients, high levels of FSH indicating primary gonadal failure, pregnancy, uncontrolled thyroid, adrenal or pituitary disorders, sex hormone dependent tumors of the reproductive tract/accessory organs, tumors of pituitary gland or hypothalamus, abnormal uterine bleeding of undetermined origin and ovarian cyst or enlargement of undetermined origin. Please scroll for full IMPORTANT RISK INFORMATION or see full Prescribing Information for Gonal-f® RFF* Redi-ject®, Gonal-f® Multi-Dose and Gonal-f® RFF* 75 IU. * RFF: Revised Formulation Female Important Risk Information for Gonal-f® RFF* Redi-ject® (follitropin alfa injection) Do not use Gonal‐f® RFF* Redi‐ject® if you:
Before using Gonal‐f® RFF* Redi‐ject®, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used, whether you have or have had asthma, abdominal surgery, ovarian cysts, polycystic ovarian disease, blood clots (thrombosis) or family history of blood clots, or are breastfeeding or plan to breastfeed. Gonal‐f® RFF* Redi‐ject® may cause serious side effects, including:
The most common side effects of Gonal‐f® RFF* Redi‐ject® include:
These are not all the possible side effects of Gonal‐f® RFF* Redi‐ject®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® RFF* Redi‐ject® as directed and do not change your dose unless directed. Do not share your Gonal‐f® RFF* Redi‐ject® and needles with another person; you may give another person an infection or get an infection from them. Carefully review the Gonal‐f® RFF* Redi‐ject® Instructions for Use that comes with the Pen for information about the correct use of Gonal‐f® RFF* Redi‐ject® and follow all training and instruction provided by your healthcare provider. Indications and Usage Gonal‐f® RFF* Redi‐ject® (follitropin alfa injection) is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
Important Risk Information for Gonal-f® Multi-Dose (follitropin alfa for injection) Do not use Gonal‐f® Multi-Dose if you:
Before using Gonal‐f® Multi-Dose, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used, whether you have or have had asthma, abdominal surgery, ovarian cysts, polycystic ovarian disease, blood clots (thrombosis) or family history of blood clots, or are breastfeeding or plan to breastfeed. Gonal‐f® Multi-Dose may cause serious side effects, including:
Other serious side effects include:
The most common side effects of Gonal‐f® Multi-Dose include
In men, common side effects include
These are not all the possible side effects of Gonal‐f®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® Multi-Dose as directed and do not change your dose unless directed. Do not share your Gonal‐f® Multi-Dose and needles with another person; you may give another person an infection or get an infection from them. Carefully review the Gonal‐f® Multi‐Dose Patient Information Leaflet that comes with the product and follow all training and instruction provided by your healthcare provider. The injection syringes provided with the product should only be used with Gonal‐f® Multi‐Dose and should not be used to administer any other drug or hormone. Indications and Usage Gonal‐f® Multi-Dose is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
Gonal‐f® Multi-Dose can also be prescribed to increase sperm production in men with a rare medical condition.
Important Risk Information for Gonal-f® RFF* 75 IU (follitropin alfa for injection) Do not use Gonal‐f® RFF* 75 IU if you:
Before using Gonal-f® RFF* 75 IU, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used. Gonal‐f® RFF* 75 IU may cause serious side effects, including:
The most common side effects of Gonal‐f® RFF* 75 IU include headache, stomach pain, stomach bloating, bruising at the injection site, and nausea. Other side effects reported include sinus infections and ovarian cysts. These are not all the possible side effects of Gonal‐f® RFF* 75 IU. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® RFF* 75 IU as directed and do not change your dose unless directed. Do not share your Gonal‐f® RFF* 75 IU and needles with another person; you may give another person an infection or get an infection from them. Indications and Usage Gonal‐f® RFF* 75 IU (follitropin alfa for injection) is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
|
Important Risk Information for Cetrotide® (cetrorelix acetate for injection) Who should not use Cetrotide®?
Before starting Cetrotide®, tell your healthcare professional about all your medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements What is the most important information I should know before starting Cetrotide®?
What are the possible side effects of Cetrotide®? Cetrotide® may cause serious side effects including:
Common side effects of using Cetrotide® include:
Call your doctor if you have any other side effect or if you are unsure about the effect of this medicine. These are not all the possible side effects of Cetrotide®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Indication What are the uses of Cetrotide®? Cetrotide® blocks the effects of a natural hormone, called gonadotropin-releasing hormone (GnRH). GnRH controls the secretion of another hormone, called luteinizing hormone (LH), which induces ovulation during the menstrual cycle. Cetrotide® blocks undesirable premature ovulation. Premature ovulation may lead to eggs that are not available for egg retrieval.
|
Important Risk Information for Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection) Who should not use Ovidrel® PreFilled Syringe? Ovidrel® Pre-Filled Syringe should not be used in patients:
Before starting Ovidrel®, tell your healthcare professional about all your medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What is the most important information I should know before taking Ovidrel?
What are the most common side effects of Ovidrel® Pre-Filled Syringe? The most common side effects in women using Ovidrel® Pre-Filled Syringe include abdominal pain, nausea, and vomiting. Needle injections may cause some discomfort. These are not all the possible side effects of Ovidrel®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Indication What are the uses of Ovidrel® Pre-Filled Syringe (choriogonadotropin alfa injection)? Ovidrel® Pre-Filled Syringe (choriogonadotropin alfa injection) is indicated for the final egg maturation to get ready for egg retrieval. Women who receive Ovidrel® have undergone pituitary desensitization and have been appropriately pre-treated with follicle stimulating hormone (FSH) as a part of an Assisted Reproductive Technology (ART) program such as in vitro (IVF) fertilization and embryo transfer. Ovidrel® Pre-Filled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in infertile patients who do not ovulate, and in whom the cause of infertility is functional and not due to primary ovarian failure
|
Summary of Contraindications Gonal-f® RFF* Redi-ject®, Gonal-f® Multi-Dose and Gonal-f® RFF* 75 IU are contraindicated in patients with prior hypersensitivity to rhFSH or excipients, high levels of FSH indicating primary gonadal failure, pregnancy, uncontrolled thyroid, adrenal or pituitary disorders, sex hormone dependent tumors of the reproductive tract/accessory organs, tumors of pituitary gland or hypothalamus, abnormal uterine bleeding of undetermined origin and ovarian cyst or enlargement of undetermined origin. Please scroll for full IMPORTANT RISK INFORMATION or see full Prescribing Information for Gonal-f® RFF* Redi-ject®, Gonal-f® Multi-Dose and Gonal-f® RFF* 75 IU. * RFF: Revised Formulation Female Important Risk Information for Gonal-f® RFF* Redi-ject® (follitropin alfa injection) Do not use Gonal‐f® RFF* Redi‐ject® if you:
Before using Gonal‐f® RFF* Redi‐ject®, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used, whether you have or have had asthma, abdominal surgery, ovarian cysts, polycystic ovarian disease, blood clots (thrombosis) or family history of blood clots, or are breastfeeding or plan to breastfeed. Gonal‐f® RFF* Redi‐ject® may cause serious side effects, including:
The most common side effects of Gonal‐f® RFF* Redi‐ject® include:
These are not all the possible side effects of Gonal‐f® RFF* Redi‐ject®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® RFF* Redi‐ject® as directed and do not change your dose unless directed. Do not share your Gonal‐f® RFF* Redi‐ject® and needles with another person; you may give another person an infection or get an infection from them. Carefully review the Gonal‐f® RFF* Redi‐ject® Instructions for Use that comes with the Pen for information about the correct use of Gonal‐f® RFF* Redi‐ject® and follow all training and instruction provided by your healthcare provider. Indications and Usage Gonal‐f® RFF* Redi‐ject® (follitropin alfa injection) is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
Important Risk Information for Gonal-f® Multi-Dose (follitropin alfa for injection) Do not use Gonal‐f® Multi-Dose if you:
Before using Gonal‐f® Multi-Dose, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used, whether you have or have had asthma, abdominal surgery, ovarian cysts, polycystic ovarian disease, blood clots (thrombosis) or family history of blood clots, or are breastfeeding or plan to breastfeed. Gonal‐f® Multi-Dose may cause serious side effects, including:
Other serious side effects include:
The most common side effects of Gonal‐f® Multi-Dose include
In men, common side effects include
These are not all the possible side effects of Gonal‐f®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® Multi-Dose as directed and do not change your dose unless directed. Do not share your Gonal‐f® Multi-Dose and needles with another person; you may give another person an infection or get an infection from them. Carefully review the Gonal‐f® Multi‐Dose Patient Information Leaflet that comes with the product and follow all training and instruction provided by your healthcare provider. The injection syringes provided with the product should only be used with Gonal‐f® Multi‐Dose and should not be used to administer any other drug or hormone. Indications and Usage Gonal‐f® Multi-Dose is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
Gonal‐f® Multi-Dose can also be prescribed to increase sperm production in men with a rare medical condition.
Important Risk Information for Gonal-f® RFF* 75 IU (follitropin alfa for injection) Do not use Gonal‐f® RFF* 75 IU if you:
Before using Gonal-f® RFF* 75 IU, tell your healthcare provider about your medical history including any prescription or over-the-counter medicines, vitamins and herbal supplements used. Gonal‐f® RFF* 75 IU may cause serious side effects, including:
The most common side effects of Gonal‐f® RFF* 75 IU include headache, stomach pain, stomach bloating, bruising at the injection site, and nausea. Other side effects reported include sinus infections and ovarian cysts. These are not all the possible side effects of Gonal‐f® RFF* 75 IU. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Use Gonal‐f® RFF* 75 IU as directed and do not change your dose unless directed. Do not share your Gonal‐f® RFF* 75 IU and needles with another person; you may give another person an infection or get an infection from them. Indications and Usage Gonal‐f® RFF* 75 IU (follitropin alfa for injection) is a prescription medicine containing follicle‐stimulating hormone (FSH) used in infertile women to:
|
Important Risk Information for Cetrotide® (cetrorelix acetate for injection) Who should not use Cetrotide®?
Before starting Cetrotide®, tell your healthcare professional about all your medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements What is the most important information I should know before starting Cetrotide®?
What are the possible side effects of Cetrotide®? Cetrotide® may cause serious side effects including:
Common side effects of using Cetrotide® include:
Call your doctor if you have any other side effect or if you are unsure about the effect of this medicine. These are not all the possible side effects of Cetrotide®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Indication What are the uses of Cetrotide®? Cetrotide® blocks the effects of a natural hormone, called gonadotropin-releasing hormone (GnRH). GnRH controls the secretion of another hormone, called luteinizing hormone (LH), which induces ovulation during the menstrual cycle. Cetrotide® blocks undesirable premature ovulation. Premature ovulation may lead to eggs that are not available for egg retrieval.
|
Important Risk Information for Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection) Who should not use Ovidrel® PreFilled Syringe? Ovidrel® Pre-Filled Syringe should not be used in patients:
Before starting Ovidrel®, tell your healthcare professional about all your medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What is the most important information I should know before taking Ovidrel?
What are the most common side effects of Ovidrel® Pre-Filled Syringe? The most common side effects in women using Ovidrel® Pre-Filled Syringe include abdominal pain, nausea, and vomiting. Needle injections may cause some discomfort. These are not all the possible side effects of Ovidrel®. For more information, read the product labeling, and ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1‐800‐FDA‐1088. Indication What are the uses of Ovidrel® Pre-Filled Syringe (choriogonadotropin alfa injection)? Ovidrel® Pre-Filled Syringe (choriogonadotropin alfa injection) is indicated for the final egg maturation to get ready for egg retrieval. Women who receive Ovidrel® have undergone pituitary desensitization and have been appropriately pre-treated with follicle stimulating hormone (FSH) as a part of an Assisted Reproductive Technology (ART) program such as in vitro (IVF) fertilization and embryo transfer. Ovidrel® Pre-Filled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in infertile patients who do not ovulate, and in whom the cause of infertility is functional and not due to primary ovarian failure
|